Latest & greatest articles for rheumatoid arthritis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on rheumatoid arthritis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on rheumatoid arthritis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for rheumatoid arthritis

41. Rheumatoid Arthritis. (PubMed)

Rheumatoid Arthritis. Rheumatoid arthritis (RA) is a common systemic inflammatory autoimmune disease characterized by painful, swollen joints that can severely impair physical function and quality of life. The presenting symptoms of musculoskeletal pain, swelling, and stiffness are common in clinical practice, so familiarity with diagnosing and managing RA is crucial. Patients with RA are at greater risk for serious infection, respiratory disease, osteoporosis, cardiovascular disease, cancer

2019 Annals of Internal Medicine

42. Baricitinib (Olumiant) - moderate to severe rheumatoid arthritis (RA)

Baricitinib (Olumiant) - moderate to severe rheumatoid arthritis (RA) Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity for SBDs written for approved after

2019 Health Canada - Drug and Health Product Register

43. The effectiveness of tai chi for rheumatoid arthritis: an overview of systematic reviews

The effectiveness of tai chi for rheumatoid arthritis: an overview of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

44. Utility values for adults with rheumatoid arthritis: a systematic review and meta-analysis

Utility values for adults with rheumatoid arthritis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

45. Th17 and regulatory T cell proportions in rheumatoid arthritis patients compared to healthy controls: a systematic review and meta-analysis

Th17 and regulatory T cell proportions in rheumatoid arthritis patients compared to healthy controls: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

46. A critical appraisal of clinical practice guidelines for the treatment or management of rheumatoid arthritis and osteoarthritis: systematic review and assessment using AGREE II

A critical appraisal of clinical practice guidelines for the treatment or management of rheumatoid arthritis and osteoarthritis: systematic review and assessment using AGREE II Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

47. Prevalence of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: a systematic review and meta-analysis

Prevalence of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

48. Effects of Nigella sativa in rheumatoid arthritis: a systematic review

Effects of Nigella sativa in rheumatoid arthritis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

49. Does non-surgical periodontal treatment influence rheumatoid arthritis? A systematic review

Does non-surgical periodontal treatment influence rheumatoid arthritis? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

50. Total knee arthroplasty (TKA) for treatment of rheumatoid arthritis (RA): a systematic review of randomized controlled trial

Total knee arthroplasty (TKA) for treatment of rheumatoid arthritis (RA): a systematic review of randomized controlled trial Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

51. The quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for the treatment or management of rheumatoid arthritis and osteoarthritis: systematic review and assessment using AGREE II

The quantity and quality of complementary and alternative medicine recommendations in clinical practice guidelines for the treatment or management of rheumatoid arthritis and osteoarthritis: systematic review and assessment using AGREE II Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission

2019 PROSPERO

52. JAK inhibitor monotherapy versus combination therapy of JAK inhibitors with methotrexate on treatment response rate and joint functionality in patients with rheumatoid arthritis- a systematic review and meta-analysis

JAK inhibitor monotherapy versus combination therapy of JAK inhibitors with methotrexate on treatment response rate and joint functionality in patients with rheumatoid arthritis- a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete

2019 PROSPERO

53. Role of diet in the management of rheumatoid arthritis: a systematic review

Role of diet in the management of rheumatoid arthritis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

54. Defining refractory disease in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis

Defining refractory disease in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

55. Comparative efficacy and safety of biosimilar-rituximab and originator-rituximab in rheumatoid arthritis and non-Hodgkin's lymphoma: a meta-analysis

Comparative efficacy and safety of biosimilar-rituximab and originator-rituximab in rheumatoid arthritis and non-Hodgkin's lymphoma: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

56. Moxibustion for rheumatoid arthritis: protocol for a systematic review

Moxibustion for rheumatoid arthritis: protocol for a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

57. Long-term improvement in joint function and pain after total knee arthroplasty in patients with rheumatoid arthritis

Long-term improvement in joint function and pain after total knee arthroplasty in patients with rheumatoid arthritis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

58. Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis

Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

59. Accuracy of digital X-ray (DXR) evaluation on hand bone loss (HBL) for diagnosis of rheumatoid arthritis (RA): a systematic review protocol

Accuracy of digital X-ray (DXR) evaluation on hand bone loss (HBL) for diagnosis of rheumatoid arthritis (RA): a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

60. Baricitinib for rheumatoid arthritis [Cochrane protocol]

Baricitinib for rheumatoid arthritis [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO